Product Image
Please see full prescribing and safety information, including boxed warning, for OXALIPLATIN vials.

Available in:

  • 50 mg per 10 mL single-use vials
  • 100 mg per 20 mL single-use vials


  • AP Rated
  • Preservative-free
  • Not made with natural rubber latex


Brand Name Equivalent: ELOXATIN® (ELOXATIN is a registered trademark of Sanofi-Aventis U.S. LLC.)
Therapeutic Category: Antineoplastic Agent

PreventIV Measures® Features:

  • Easy-to-read drug name and dosage strength to aid in identifying the right product
  • Bar codes included on the vial and carton for ease of scanning
  • Unique label design to help products stand out on the shelf
  • Enhanced packaging and labeling designed to promote safety and help reduce the risk of medication errors
  • Yellow and black cytotoxic caution flag designed to alert healthcare workers who handle the product
Description Strength Fill
Concentration Container
Closure Unit
of Sale
233-10 Glass Vial 50 mg 10 mL 5 mg per mL 20 mL 20 mm 1
233-20 Glass Vial 100 mg 20 mL 5 mg per mL 20 mL 20 mm 1
WARNING: HYPERSENSITIVITY REACTIONS, INCLUDING ANAPHYLAXIS Serious and fatal hypersensitivity adverse reactions, including anaphylaxis, can occur with Oxaliplatin Injection within minutes of administration and during any cycle. Oxaliplatin Injection is contraindicated in patients with hypersensitivity reactions to oxaliplatin and other platinum-based drugs [see Contraindications (4)]. Immediately and permanently discontinue Oxaliplatin Injection for hypersensitivity reactions and administer appropriate treatment for management of the hypersensitivity reaction [see Warnings and Precautions (5.1)].